Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-world Study of Fruquintinib in the Cross-line Treatment of Refractory mCRC

NCT06099314 is registered in ClinicalTrials.gov with Union Hospital, Tongji Medical College, Huazhong University of Science and Technology as lead sponsor.

NCT NCT06099314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06099314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-world Study of Fruquintinib in the Cross-line Treatment of Refractory mCRC
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2023
Completion date
September 30, 2025
Enrollment
36 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

fruquintinib, metastatic colorectal cancer